Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
09/2003
09/04/2003US20030166164 IL-17 like molecules and uses thereof
09/04/2003US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/04/2003US20030166151 Comprises peptides of ionotropic glutamate receptor for diagnosing and treating nervous system disorders; drug screening
09/04/2003US20030165958 Test and model for Alzheimer's disease
09/04/2003US20030165930 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
09/04/2003US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms
09/04/2003US20030165862 Generating modified fly flippase recombination target sequences to act as site of genetic exchange during transposon-induced mutagenesis
09/04/2003US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry
09/04/2003US20030165501 Protein antagonist; insulin resistance; muscle disorders
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165491 Anticancer agents; controlling cell differentiation; complexing; insertion plasmids; genetic engineering
09/04/2003US20030165490 22196, a novel human aminopeptidase
09/04/2003US20030165480 Using swine organs; controlling gene expression
09/04/2003CA2477632A1 Animal derived from manipulated embryo and preparing method thereof
09/04/2003CA2477624A1 Transgenic zebrafish models for thrombosis
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477112A1 A method for producing germline chimeric animal
09/04/2003CA2476041A1 Delta 6-desaturases from primulaceae, expressing plants and pufa-containing oils
09/04/2003CA2385734A1 Transgenic cardiomyoctes with controlled proliferation and differentiation
09/03/2003EP1340424A1 Double transgenic animal model for Alzheimer's disease
09/03/2003EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof
09/03/2003EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339844A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339843A2 Human transporter proteins nucleic acid molecules encoding them and uses thereof
09/03/2003EP1339842A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339840A2 Schizophrenia-related voltage-gated ion channel gene and protein
09/03/2003EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1250418A4 Methods for identifying anti-cancer drug targets
09/03/2003EP0684831B1 Allogenic vaccine and method to synthesize same
09/03/2003CN1440236A Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same
09/03/2003CN1119929C Pig embryo regulation factor and its preparing process and application
09/02/2003US6613958 Genome comprising nucleotide sequence encoding a human matrix metalloproteinase and a fusion polypeptide; used for diagnosis and treatment of cartilage-degenerative disease
09/02/2003US6613957 Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic non-human mammals
09/02/2003US6613956 Transgenic fly comprising a polynucleotide sequence under regulatory control of an eye specific promoter; phenotypic change in eye; can use for reducing cell death after trauma and treatment of cancer and diabetes
09/02/2003US6613544 Osteoprotegerin
08/2003
08/28/2003WO2003071267A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
08/28/2003WO2003070961A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003WO2003070771A1 Rrp sequences and knockout mice and uses thereof
08/28/2003WO2003070752A2 Mhc-peptide complex binding ligands
08/28/2003WO2003069984A2 Transgenic production in saliva
08/28/2003WO2003055911A3 Cystine-knot fold protein
08/28/2003WO2003028756A3 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions
08/28/2003WO2003025183A3 Random integration of a polynucleotide after in vivo linearization
08/28/2003WO2003014153A3 Cellular virus receptors and methods of use.
08/28/2003WO2003013429A3 A programmable electronic maze for use in the assessment of animal behaviour
08/28/2003WO2002103472A3 Pet food kiosk
08/28/2003WO2002044736A3 Diagnosis and treatment of epidermal or skin diseases
08/28/2003WO2002043478A3 Transgenic transchromosomal rodents for making human antibodies
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2002007752A3 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
08/28/2003US20030163836 In situ detection of enzyme inhibitors
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162947 Rapid production of monoclonal antibodies
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162292 Transgenic zebrafish (models) comprising plasmid for green fluorescent protein integrated within genome for analyzing heart-related gene functions and gene therapy
08/28/2003US20030162291 Clk-2, cex-7 and coq-4 genes, and uses thereof
08/28/2003US20030162278 Use for development of human therapeutic proteins; amino acid sequences, allelic variants, isolated polypeptide, antibody and nucleic acids, transgenic non-human animal, culturing the host cell, genetic engineering
08/28/2003US20030162274 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/28/2003US20030162238 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
08/28/2003CA2476894A1 Transgenic production in saliva
08/28/2003CA2476761A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors
08/28/2003CA2476625A1 Mhc-peptide complex binding ligands
08/28/2003CA2476362A1 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/27/2003EP1338653A2 Improvement of an expression vector for production of recombinant proteins
08/27/2003EP1338198A1 Method of constructing mouse suitable for the take, differentiation and proliferation of heterogenous cells, mouse constructed by this method and use of the mouse
08/27/2003EP1337650A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337634A2 Novel polypeptides involved in immune response
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337282A2 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP0750458B1 Terminal complement inhibitor fusion genes and proteins
08/27/2003CN1438317A Method for producing purposive protein using homologous recombination method to obtain transgenosis tussah
08/27/2003CN1437845A Method for refrigerating presevation of zhonghua villiform chela crab
08/26/2003US6611766 Quantitative and qualitative analysis of immunologically or pathologically affected cells; two dimensional gel electrophoresis; generating master composite image
08/26/2003US6610905 Transgenic mouse model for Kaposi's sarcoma
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610656 Activating osteogenesis using hedgehog genes or proteins coded by hybridized nucleic acids
08/26/2003US6610511 Drosophila odorant receptors
08/26/2003US6610503 Animal models for predicting sepsis mortality
08/26/2003US6610493 Screening compounds for the ability to alter the production of amyloid-β peptide
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610333 Feed supplement for arthropods
08/21/2003WO2003068971A1 Method of expressing an encoding sequence by xenoplus cells
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068960A1 Transposon being functional in mammals
08/21/2003WO2003068915A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
08/21/2003WO2003068153A2 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2002083838A3 Elimination of endogenous porcine retrovirus
08/21/2003WO2002083182A3 The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002064731B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2002006535A3 Method for breeding disease resistant domesticated fowl
08/21/2003WO2001090342A3 Genetic engineering of vascular grafts to resist disease